#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat|salience|identity
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Description :
1-1	0-11	Description	abstract[1]	new[1]	nonsal[1]	_	_	_	
1-2	12-13	:	_	_	_	_	_	_	

#Text=Human immunodeficiency virus disease with stable control on Atripla .
2-1	14-19	Human	abstract[2]|animal[3]	new[2]|new[3]	sal[2]|nonsal[3]	_	coref|coref	6-3[14_2]|7-16[19_3]	
2-2	20-36	immunodeficiency	abstract[2]|animal[3]	new[2]|new[3]	sal[2]|nonsal[3]	_	_	_	
2-3	37-42	virus	abstract[2]|animal[3]	new[2]|new[3]	sal[2]|nonsal[3]	_	_	_	
2-4	43-50	disease	abstract[2]	new[2]	sal[2]	_	_	_	
2-5	51-55	with	abstract[2]	new[2]	sal[2]	_	_	_	
2-6	56-62	stable	abstract[2]	new[2]	sal[2]	_	_	_	
2-7	63-70	control	abstract[2]	new[2]	sal[2]	_	_	_	
2-8	71-73	on	abstract[2]	new[2]	sal[2]	_	_	_	
2-9	74-81	Atripla	abstract[2]|substance[4]	new[2]|new[4]	sal[2]|sal[4]	Efavirenz/emtricitabine/tenofovir[4]	coref	24-2[84_4]	
2-10	82-83	.	_	_	_	_	_	_	

#Text=Resolving left gluteal abscess , completing Flagyl .
3-1	84-93	Resolving	_	_	_	_	_	_	
3-2	94-98	left	object[5]	new[5]	sal[5]	_	coref	9-6[28_5]	
3-3	99-106	gluteal	object[5]	new[5]	sal[5]	_	_	_	
3-4	107-114	abscess	object[5]	new[5]	sal[5]	_	_	_	
3-5	115-116	,	_	_	_	_	_	_	
3-6	117-127	completing	_	_	_	_	_	_	
3-7	128-134	Flagyl	substance[6]	new[6]	nonsal[6]	Metronidazole[6]	coref	21-2[75_6]	
3-8	135-136	.	_	_	_	_	_	_	

#Text=Diabetes mellitus , currently on oral therapy .
4-1	137-145	Diabetes	abstract[7]	new[7]	sal[7]	Diabetes[7]	coref	9-22[32_7]	
4-2	146-154	mellitus	abstract[7]	new[7]	sal[7]	Diabetes[7]	_	_	
4-3	155-156	,	_	_	_	_	_	_	
4-4	157-166	currently	_	_	_	_	_	_	
4-5	167-169	on	_	_	_	_	_	_	
4-6	170-174	oral	abstract[8]	new[8]	sal[8]	_	coref	42-7[144_8]	
4-7	175-182	therapy	abstract[8]	new[8]	sal[8]	_	_	_	
4-8	183-184	.	_	_	_	_	_	_	

#Text=Hypertension , depression , and chronic musculoskeletal pain of unclear etiology .
5-1	185-197	Hypertension	abstract[9]	new[9]	sal[9]	_	coref	10-7[35_9]	
5-2	198-199	,	_	_	_	_	_	_	
5-3	200-210	depression	abstract[10]	new[10]	sal[10]	_	coref	44-2[146_10]	
5-4	211-212	,	_	_	_	_	_	_	
5-5	213-216	and	_	_	_	_	_	_	
5-6	217-224	chronic	abstract[11]	new[11]	sal[11]	_	coref	45-2[147_11]	
5-7	225-240	musculoskeletal	abstract[11]	new[11]	sal[11]	_	_	_	
5-8	241-245	pain	abstract[11]	new[11]	sal[11]	_	_	_	
5-9	246-248	of	abstract[11]	new[11]	sal[11]	_	_	_	
5-10	249-256	unclear	abstract[11]|abstract[12]	new[11]|new[12]	sal[11]|nonsal[12]	_	coref	45-6[148_12]	
5-11	257-265	etiology	abstract[11]|abstract[12]	new[11]|new[12]	sal[11]|nonsal[12]	_	_	_	
5-12	266-267	.	_	_	_	_	_	_	

#Text=HISTORY OF PRESENT ILLNESS :
6-1	268-275	HISTORY	abstract[13]	new[13]	nonsal[13]	_	coref	7-13[17_13]	
6-2	276-278	OF	abstract[13]	new[13]	nonsal[13]	_	_	_	
6-3	279-286	PRESENT	abstract[13]|abstract[14]	new[13]|giv[14]	nonsal[13]|nonsal[14]	_	coref	7-16[18_14]	
6-4	287-294	ILLNESS	abstract[13]|abstract[14]	new[13]|giv[14]	nonsal[13]|nonsal[14]	_	_	_	
6-5	295-296	:	_	_	_	_	_	_	

#Text=The patient is a 41 - year - old white male with a history of HIV disease .
7-1	297-300	The	person[15]	new[15]	sal[15]	_	coref	7-4[16_15]	
7-2	301-308	patient	person[15]	new[15]	sal[15]	_	_	_	
7-3	309-311	is	_	_	_	_	_	_	
7-4	312-313	a	person[16]	giv[16]	nonsal[16]	_	coref	8-1[21_16]	
7-5	314-316	41	person[16]	giv[16]	nonsal[16]	_	_	_	
7-6	317-318	-	person[16]	giv[16]	nonsal[16]	_	_	_	
7-7	319-323	year	person[16]	giv[16]	nonsal[16]	_	_	_	
7-8	324-325	-	person[16]	giv[16]	nonsal[16]	_	_	_	
7-9	326-329	old	person[16]	giv[16]	nonsal[16]	_	_	_	
7-10	330-335	white	person[16]	giv[16]	nonsal[16]	_	_	_	
7-11	336-340	male	person[16]	giv[16]	nonsal[16]	_	_	_	
7-12	341-345	with	person[16]	giv[16]	nonsal[16]	_	_	_	
7-13	346-347	a	person[16]|abstract[17]	giv[16]|new[17]	nonsal[16]|nonsal[17]	_	_	_	
7-14	348-355	history	person[16]|abstract[17]	giv[16]|new[17]	nonsal[16]|nonsal[17]	_	_	_	
7-15	356-358	of	person[16]|abstract[17]	giv[16]|new[17]	nonsal[16]|nonsal[17]	_	_	_	
7-16	359-362	HIV	person[16]|abstract[17]|abstract[18]|animal[19]	giv[16]|new[17]|giv[18]|new[19]	nonsal[16]|nonsal[17]|nonsal[18]|nonsal[19]	HIV[19]	coref|coref	40-2[138_18]|40-2[139_19]	
7-17	363-370	disease	person[16]|abstract[17]|abstract[18]	giv[16]|new[17]|giv[18]	nonsal[16]|nonsal[17]|nonsal[18]	_	_	_	
7-18	371-372	.	_	_	_	_	_	_	

#Text=His last CD4 count was 425 , viral load was less than 50 in 08 / 07 .
8-1	373-376	His	abstract[20]|person[21]	new[20]|giv[21]	nonsal[20]|nonsal[21]	_	coref|coref	8-6[23_20]|9-1[27_21]	
8-2	377-381	last	abstract[20]	new[20]	nonsal[20]	_	_	_	
8-3	382-385	CD4	abstract[20]|animal[22]	new[20]|new[22]	nonsal[20]|nonsal[22]	CD4[22]	_	_	
8-4	386-391	count	abstract[20]	new[20]	nonsal[20]	_	_	_	
8-5	392-395	was	_	_	_	_	_	_	
8-6	396-399	425	abstract[23]	new[23]	nonsal[23]	_	_	_	
8-7	400-401	,	_	_	_	_	_	_	
8-8	402-407	viral	abstract[24]	new[24]	nonsal[24]	_	_	_	
8-9	408-412	load	abstract[24]	new[24]	nonsal[24]	_	_	_	
8-10	413-416	was	_	_	_	_	_	_	
8-11	417-421	less	_	_	_	_	_	_	
8-12	422-426	than	_	_	_	_	_	_	
8-13	427-429	50	abstract[25]	new[25]	nonsal[25]	_	_	_	
8-14	430-432	in	_	_	_	_	_	_	
8-15	433-435	08	time[26]	new[26]	nonsal[26]	_	_	_	
8-16	436-437	/	time[26]	new[26]	nonsal[26]	_	_	_	
8-17	438-440	07	time[26]	new[26]	nonsal[26]	_	_	_	
8-18	441-442	.	_	_	_	_	_	_	

#Text=He was recently hospitalized for left gluteal abscess , for which he underwent I & D and he has newly diagnosed diabetes mellitus .
9-1	443-445	He	person[27]	giv[27]	nonsal[27]	_	coref	9-12[29_27]	
9-2	446-449	was	_	_	_	_	_	_	
9-3	450-458	recently	_	_	_	_	_	_	
9-4	459-471	hospitalized	_	_	_	_	_	_	
9-5	472-475	for	_	_	_	_	_	_	
9-6	476-480	left	object[28]	new[28]	nonsal[28]	_	coref	12-22[46_28]	
9-7	481-488	gluteal	object[28]	new[28]	nonsal[28]	_	_	_	
9-8	489-496	abscess	object[28]	new[28]	nonsal[28]	_	_	_	
9-9	497-498	,	object[28]	new[28]	nonsal[28]	_	_	_	
9-10	499-502	for	object[28]	new[28]	nonsal[28]	_	_	_	
9-11	503-508	which	object[28]	new[28]	nonsal[28]	_	_	_	
9-12	509-511	he	object[28]|person[29]	new[28]|giv[29]	nonsal[28]|nonsal[29]	_	coref	9-18[31_29]	
9-13	512-521	underwent	object[28]	new[28]	nonsal[28]	_	_	_	
9-14	522-523	I	object[28]|event[30]	new[28]|new[30]	nonsal[28]|nonsal[30]	_	_	_	
9-15	524-525	&	object[28]|event[30]	new[28]|new[30]	nonsal[28]|nonsal[30]	_	_	_	
9-16	526-527	D	object[28]|event[30]	new[28]|new[30]	nonsal[28]|nonsal[30]	_	_	_	
9-17	528-531	and	_	_	_	_	_	_	
9-18	532-534	he	person[31]	giv[31]	nonsal[31]	_	coref	10-1[33_31]	
9-19	535-538	has	_	_	_	_	_	_	
9-20	539-544	newly	_	_	_	_	_	_	
9-21	545-554	diagnosed	_	_	_	_	_	_	
9-22	555-563	diabetes	abstract[32]	giv[32]	nonsal[32]	Diabetes[32]	coref	42-2[143_32]	
9-23	564-572	mellitus	abstract[32]	giv[32]	nonsal[32]	Diabetes[32]	_	_	
9-24	573-574	.	_	_	_	_	_	_	

#Text=He also has a history of hypertension and hypertriglyceridemia .
10-1	575-577	He	person[33]	giv[33]	nonsal[33]	_	coref	11-1[37_33]	
10-2	578-582	also	_	_	_	_	_	_	
10-3	583-586	has	_	_	_	_	_	_	
10-4	587-588	a	abstract[34]	new[34]	nonsal[34]	_	_	_	
10-5	589-596	history	abstract[34]	new[34]	nonsal[34]	_	_	_	
10-6	597-599	of	abstract[34]	new[34]	nonsal[34]	_	_	_	
10-7	600-612	hypertension	abstract[34]|abstract[35]	new[34]|giv[35]	nonsal[34]|nonsal[35]	_	coref	43-2[145_35]	
10-8	613-616	and	abstract[34]	new[34]	nonsal[34]	_	_	_	
10-9	617-637	hypertriglyceridemia	abstract[34]|abstract[36]	new[34]|new[36]	nonsal[34]|nonsal[36]	_	_	_	
10-10	638-639	.	_	_	_	_	_	_	

#Text=He had been having increased urination and thirst .
11-1	640-642	He	person[37]	giv[37]	nonsal[37]	_	coref	12-1[40_37]	
11-2	643-646	had	_	_	_	_	_	_	
11-3	647-651	been	_	_	_	_	_	_	
11-4	652-658	having	_	_	_	_	_	_	
11-5	659-668	increased	_	_	_	_	_	_	
11-6	669-678	urination	event[38]	new[38]	nonsal[38]	_	_	_	
11-7	679-682	and	_	_	_	_	_	_	
11-8	683-689	thirst	abstract[39]	new[39]	nonsal[39]	_	_	_	
11-9	690-691	.	_	_	_	_	_	_	

#Text=He was seen in the hospital by the endocrinology staff and treated with insulin while hospitalized and getting treatment for his perirectal abscess .
12-1	692-694	He	person[40]	giv[40]	nonsal[40]	_	coref	12-21[45_40]	
12-2	695-698	was	_	_	_	_	_	_	
12-3	699-703	seen	_	_	_	_	_	_	
12-4	704-706	in	_	_	_	_	_	_	
12-5	707-710	the	place[41]	acc[41]	nonsal[41]	_	bridge	12-8[42_41]	
12-6	711-719	hospital	place[41]	acc[41]	nonsal[41]	_	_	_	
12-7	720-722	by	_	_	_	_	_	_	
12-8	723-726	the	person[42]	acc[42]	nonsal[42]	_	_	_	
12-9	727-740	endocrinology	person[42]	acc[42]	nonsal[42]	_	_	_	
12-10	741-746	staff	person[42]	acc[42]	nonsal[42]	_	_	_	
12-11	747-750	and	_	_	_	_	_	_	
12-12	751-758	treated	_	_	_	_	_	_	
12-13	759-763	with	_	_	_	_	_	_	
12-14	764-771	insulin	substance[43]	new[43]	nonsal[43]	_	coref	13-7[48_43]	
12-15	772-777	while	_	_	_	_	_	_	
12-16	778-790	hospitalized	_	_	_	_	_	_	
12-17	791-794	and	_	_	_	_	_	_	
12-18	795-802	getting	_	_	_	_	_	_	
12-19	803-812	treatment	abstract[44]	new[44]	nonsal[44]	_	_	_	
12-20	813-816	for	abstract[44]	new[44]	nonsal[44]	_	_	_	
12-21	817-820	his	abstract[44]|person[45]	new[44]|giv[45]	nonsal[44]|nonsal[45]	_	coref	13-12[49_45]	
12-22	821-831	perirectal	abstract[44]|object[46]	new[44]|giv[46]	nonsal[44]|nonsal[46]	_	coref	16-4[60_46]	
12-23	832-839	abscess	abstract[44]|object[46]	new[44]|giv[46]	nonsal[44]|nonsal[46]	_	_	_	
12-24	840-841	.	_	_	_	_	_	_	

#Text=The endocrine team apparently felt that insulin might be best for this patient , but because of financial issues , elected to place him on Glucophage and glyburide .
13-1	842-845	The	organization[47]	new[47]	nonsal[47]	_	_	_	
13-2	846-855	endocrine	organization[47]	new[47]	nonsal[47]	_	_	_	
13-3	856-860	team	organization[47]	new[47]	nonsal[47]	_	_	_	
13-4	861-871	apparently	_	_	_	_	_	_	
13-5	872-876	felt	_	_	_	_	_	_	
13-6	877-881	that	_	_	_	_	_	_	
13-7	882-889	insulin	substance[48]	giv[48]	nonsal[48]	_	_	_	
13-8	890-895	might	_	_	_	_	_	_	
13-9	896-898	be	_	_	_	_	_	_	
13-10	899-903	best	_	_	_	_	_	_	
13-11	904-907	for	_	_	_	_	_	_	
13-12	908-912	this	person[49]	giv[49]	nonsal[49]	_	coref	13-24[51_49]	
13-13	913-920	patient	person[49]	giv[49]	nonsal[49]	_	_	_	
13-14	921-922	,	_	_	_	_	_	_	
13-15	923-926	but	_	_	_	_	_	_	
13-16	927-934	because	_	_	_	_	_	_	
13-17	935-937	of	_	_	_	_	_	_	
13-18	938-947	financial	abstract[50]	new[50]	nonsal[50]	_	_	_	
13-19	948-954	issues	abstract[50]	new[50]	nonsal[50]	_	_	_	
13-20	955-956	,	_	_	_	_	_	_	
13-21	957-964	elected	_	_	_	_	_	_	
13-22	965-967	to	_	_	_	_	_	_	
13-23	968-973	place	_	_	_	_	_	_	
13-24	974-977	him	person[51]	giv[51]	nonsal[51]	_	coref	14-1[55_51]	
13-25	978-980	on	_	_	_	_	_	_	
13-26	981-991	Glucophage	substance[52]|substance[53]	new[52]|new[53]	nonsal[52]|nonsal[53]	Metformin[53]	coref	14-9[57_52]	
13-27	992-995	and	substance[52]	new[52]	nonsal[52]	_	_	_	
13-28	996-1005	glyburide	substance[52]|substance[54]	new[52]|new[54]	nonsal[52]|nonsal[54]	Glibenclamide[54]	_	_	
13-29	1006-1007	.	_	_	_	_	_	_	

#Text=The patient reports that he has been taking the medication .
14-1	1008-1011	The	person[55]	giv[55]	nonsal[55]	_	coref	14-5[56_55]	
14-2	1012-1019	patient	person[55]	giv[55]	nonsal[55]	_	_	_	
14-3	1020-1027	reports	_	_	_	_	_	_	
14-4	1028-1032	that	_	_	_	_	_	_	
14-5	1033-1035	he	person[56]	giv[56]	nonsal[56]	_	coref	15-1[58_56]	
14-6	1036-1039	has	_	_	_	_	_	_	
14-7	1040-1044	been	_	_	_	_	_	_	
14-8	1045-1051	taking	_	_	_	_	_	_	
14-9	1052-1055	the	substance[57]	new[57]	nonsal[57]	_	_	_	
14-10	1056-1066	medication	substance[57]	new[57]	nonsal[57]	_	_	_	
14-11	1067-1068	.	_	_	_	_	_	_	

#Text=He is in general feeling better .
15-1	1069-1071	He	person[58]	giv[58]	nonsal[58]	_	coref	16-1[59_58]	
15-2	1072-1074	is	_	_	_	_	_	_	
15-3	1075-1077	in	_	_	_	_	_	_	
15-4	1078-1085	general	_	_	_	_	_	_	
15-5	1086-1093	feeling	_	_	_	_	_	_	
15-6	1094-1100	better	_	_	_	_	_	_	
15-7	1101-1102	.	_	_	_	_	_	_	

#Text=He says that his gluteal abscess is improving and he will be following up with Surgery today .
16-1	1103-1105	He	person[59]	giv[59]	nonsal[59]	_	coref	16-4[61_59]	
16-2	1106-1110	says	_	_	_	_	_	_	
16-3	1111-1115	that	_	_	_	_	_	_	
16-4	1116-1119	his	object[60]|person[61]	giv[60]|giv[61]	nonsal[60]|nonsal[61]	_	coref|coref	38-8[135_60]|16-10[62_61]	
16-5	1120-1127	gluteal	object[60]	giv[60]	nonsal[60]	_	_	_	
16-6	1128-1135	abscess	object[60]	giv[60]	nonsal[60]	_	_	_	
16-7	1136-1138	is	_	_	_	_	_	_	
16-8	1139-1148	improving	_	_	_	_	_	_	
16-9	1149-1152	and	_	_	_	_	_	_	
16-10	1153-1155	he	person[62]	giv[62]	nonsal[62]	_	coref	28-1[96_62]	
16-11	1156-1160	will	_	_	_	_	_	_	
16-12	1161-1163	be	_	_	_	_	_	_	
16-13	1164-1173	following	_	_	_	_	_	_	
16-14	1174-1176	up	_	_	_	_	_	_	
16-15	1177-1181	with	_	_	_	_	_	_	
16-16	1182-1189	Surgery	event[63]	new[63]	nonsal[63]	_	_	_	
16-17	1190-1195	today	time[64]	acc[64]	nonsal[64]	_	_	_	
16-18	1196-1197	.	_	_	_	_	_	_	

#Text=CURRENT MEDICATIONS :
17-1	1198-1205	CURRENT	abstract[65]	new[65]	sal[65]	_	coref	46-7[151_65]	
17-2	1206-1217	MEDICATIONS	abstract[65]	new[65]	sal[65]	_	_	_	
17-3	1218-1219	:	_	_	_	_	_	_	

#Text=1. Gabapentin 600 mg at night .
18-1	1220-1222	1.	_	_	_	_	_	_	
18-2	1223-1233	Gabapentin	substance[66]	new[66]	sal[66]	Gabapentin[66]	_	_	
18-3	1234-1237	600	substance[67]	new[67]	nonsal[67]	_	_	_	
18-4	1238-1240	mg	substance[67]	new[67]	nonsal[67]	_	_	_	
18-5	1241-1243	at	_	_	_	_	_	_	
18-6	1244-1249	night	time[68]	new[68]	nonsal[68]	_	coref	24-5[86_68]	
18-7	1250-1251	.	_	_	_	_	_	_	

#Text=2. Metformin 1000 mg twice a day .
19-1	1252-1254	2.	_	_	_	_	_	_	
19-2	1255-1264	Metformin	substance[69]	new[69]	sal[69]	Metformin[69]	_	_	
19-3	1265-1269	1000	substance[70]	new[70]	nonsal[70]	_	_	_	
19-4	1270-1272	mg	substance[70]	new[70]	nonsal[70]	_	_	_	
19-5	1273-1278	twice	_	_	_	_	_	_	
19-6	1279-1280	a	time[71]	new[71]	nonsal[71]	_	coref	20-5[74_71]	
19-7	1281-1284	day	time[71]	new[71]	nonsal[71]	_	_	_	
19-8	1285-1286	.	_	_	_	_	_	_	

#Text=3. Glipizide 5 mg a day .
20-1	1287-1289	3.	_	_	_	_	_	_	
20-2	1290-1299	Glipizide	substance[72]	new[72]	sal[72]	Glipizide[72]	_	_	
20-3	1300-1301	5	substance[73]	new[73]	nonsal[73]	_	_	_	
20-4	1302-1304	mg	substance[73]	new[73]	nonsal[73]	_	_	_	
20-5	1305-1306	a	time[74]	giv[74]	nonsal[74]	_	coref	21-7[77_74]	
20-6	1307-1310	day	time[74]	giv[74]	nonsal[74]	_	_	_	
20-7	1311-1312	.	_	_	_	_	_	_	

#Text=4. Flagyl 500 mg four times a day .
21-1	1313-1315	4.	_	_	_	_	_	_	
21-2	1316-1322	Flagyl	substance[75]	giv[75]	nonsal[75]	Metronidazole[75]	coref	41-8[142_75]	
21-3	1323-1326	500	substance[76]	new[76]	nonsal[76]	_	_	_	
21-4	1327-1329	mg	substance[76]	new[76]	nonsal[76]	_	_	_	
21-5	1330-1334	four	_	_	_	_	_	_	
21-6	1335-1340	times	_	_	_	_	_	_	
21-7	1341-1342	a	time[77]	giv[77]	nonsal[77]	_	coref	22-6[80_77]	
21-8	1343-1346	day	time[77]	giv[77]	nonsal[77]	_	_	_	
21-9	1347-1348	.	_	_	_	_	_	_	

#Text=5. Flexeril 10 mg twice a day .
22-1	1349-1351	5.	_	_	_	_	_	_	
22-2	1352-1360	Flexeril	substance[78]	new[78]	nonsal[78]	Cyclobenzaprine[78]	_	_	
22-3	1361-1363	10	substance[79]	new[79]	nonsal[79]	_	_	_	
22-4	1364-1366	mg	substance[79]	new[79]	nonsal[79]	_	_	_	
22-5	1367-1372	twice	_	_	_	_	_	_	
22-6	1373-1374	a	time[80]	giv[80]	nonsal[80]	_	coref	23-5[83_80]	
22-7	1375-1378	day	time[80]	giv[80]	nonsal[80]	_	_	_	
22-8	1379-1380	.	_	_	_	_	_	_	

#Text=6. Paroxetine 20 mg a day .
23-1	1381-1383	6.	_	_	_	_	_	_	
23-2	1384-1394	Paroxetine	substance[81]	new[81]	nonsal[81]	Paroxetine[81]	_	_	
23-3	1395-1397	20	substance[82]	new[82]	nonsal[82]	_	_	_	
23-4	1398-1400	mg	substance[82]	new[82]	nonsal[82]	_	_	_	
23-5	1401-1402	a	time[83]	giv[83]	nonsal[83]	_	coref	25-6[89_83]	
23-6	1403-1406	day	time[83]	giv[83]	nonsal[83]	_	_	_	
23-7	1407-1408	.	_	_	_	_	_	_	

#Text=7. Atripla one at night .
24-1	1409-1411	7.	_	_	_	_	_	_	
24-2	1412-1419	Atripla	substance[84]	giv[84]	nonsal[84]	Efavirenz/emtricitabine/tenofovir[84]	coref	40-10[140_84]	
24-3	1420-1423	one	object[85]	new[85]	nonsal[85]	_	_	_	
24-4	1424-1426	at	_	_	_	_	_	_	
24-5	1427-1432	night	time[86]	giv[86]	nonsal[86]	_	_	_	
24-6	1433-1434	.	_	_	_	_	_	_	

#Text=8. Clonazepam 1 mg twice a day .
25-1	1435-1437	8.	_	_	_	_	_	_	
25-2	1438-1448	Clonazepam	substance[87]	new[87]	nonsal[87]	Clonazepam[87]	_	_	
25-3	1449-1450	1	substance[88]	new[88]	nonsal[88]	_	_	_	
25-4	1451-1453	mg	substance[88]	new[88]	nonsal[88]	_	_	_	
25-5	1454-1459	twice	_	_	_	_	_	_	
25-6	1460-1461	a	time[89]	giv[89]	nonsal[89]	_	_	_	
25-7	1462-1465	day	time[89]	giv[89]	nonsal[89]	_	_	_	
25-8	1466-1467	.	_	_	_	_	_	_	

#Text=9. Blood pressure medicine , name unknown .
26-1	1468-1470	9.	_	_	_	_	_	_	
26-2	1471-1476	Blood	abstract[90]|abstract[91]|substance[92]	new[90]|new[91]|new[92]	nonsal[90]|nonsal[91]|nonsal[92]	_	bridge|coref|coref	26-6[93_90]|30-7[103_91]|30-7[104_92]	
26-3	1477-1485	pressure	abstract[90]|abstract[91]	new[90]|new[91]	nonsal[90]|nonsal[91]	_	_	_	
26-4	1486-1494	medicine	abstract[90]	new[90]	nonsal[90]	_	_	_	
26-5	1495-1496	,	_	_	_	_	_	_	
26-6	1497-1501	name	abstract[93]	acc[93]	nonsal[93]	_	_	_	
26-7	1502-1509	unknown	_	_	_	_	_	_	
26-8	1510-1511	.	_	_	_	_	_	_	

#Text=REVIEW OF SYSTEMS :
27-1	1512-1518	REVIEW	abstract[94]	new[94]	nonsal[94]	_	_	_	
27-2	1519-1521	OF	abstract[94]	new[94]	nonsal[94]	_	_	_	
27-3	1522-1529	SYSTEMS	abstract[94]|abstract[95]	new[94]|new[95]	nonsal[94]|nonsal[95]	_	coref	28-8[98_95]	
27-4	1530-1531	:	_	_	_	_	_	_	

#Text=He otherwise has a negative review of systems .
28-1	1532-1534	He	person[96]	giv[96]	nonsal[96]	_	coref	32-1[116_96]	
28-2	1535-1544	otherwise	_	_	_	_	_	_	
28-3	1545-1548	has	_	_	_	_	_	_	
28-4	1549-1550	a	abstract[97]	new[97]	nonsal[97]	_	_	_	
28-5	1551-1559	negative	abstract[97]	new[97]	nonsal[97]	_	_	_	
28-6	1560-1566	review	abstract[97]	new[97]	nonsal[97]	_	_	_	
28-7	1567-1569	of	abstract[97]	new[97]	nonsal[97]	_	_	_	
28-8	1570-1577	systems	abstract[97]|abstract[98]	new[97]|giv[98]	nonsal[97]|nonsal[98]	_	_	_	
28-9	1578-1579	.	_	_	_	_	_	_	

#Text=PHYSICAL EXAMINATION :
29-1	1580-1588	PHYSICAL	abstract[99]	new[99]	nonsal[99]	_	_	_	
29-2	1589-1600	EXAMINATION	abstract[99]	new[99]	nonsal[99]	_	_	_	
29-3	1601-1602	:	_	_	_	_	_	_	

#Text=VITAL SIGNS : Temperature 36.6 , blood pressure 145 / 90 , pulse 123 , respirations 20 , and weight is 89.9 kg ( 198 pounds . )
30-1	1603-1608	VITAL	abstract[100]	new[100]	nonsal[100]	_	_	_	
30-2	1609-1614	SIGNS	abstract[100]	new[100]	nonsal[100]	_	_	_	
30-3	1615-1616	:	_	_	_	_	_	_	
30-4	1617-1628	Temperature	abstract[101]	new[101]	nonsal[101]	_	coref	30-5[102_101]	
30-5	1629-1633	36.6	abstract[102]	new[102]	nonsal[102]	_	_	_	
30-6	1634-1635	,	_	_	_	_	_	_	
30-7	1636-1641	blood	abstract[103]|substance[104]	giv[103]|giv[104]	nonsal[103]|nonsal[104]	_	coref	30-9[105_103]	
30-8	1642-1650	pressure	abstract[103]	giv[103]	nonsal[103]	_	_	_	
30-9	1651-1654	145	abstract[105]	giv[105]	nonsal[105]	_	_	_	
30-10	1655-1656	/	abstract[105]	giv[105]	nonsal[105]	_	_	_	
30-11	1657-1659	90	abstract[105]	giv[105]	nonsal[105]	_	_	_	
30-12	1660-1661	,	_	_	_	_	_	_	
30-13	1662-1667	pulse	abstract[106]	new[106]	nonsal[106]	_	coref	30-14[107_106]	
30-14	1668-1671	123	abstract[107]	giv[107]	nonsal[107]	_	_	_	
30-15	1672-1673	,	_	_	_	_	_	_	
30-16	1674-1686	respirations	abstract[108]	new[108]	nonsal[108]	_	coref	30-17[109_108]	
30-17	1687-1689	20	abstract[109]	giv[109]	nonsal[109]	_	_	_	
30-18	1690-1691	,	_	_	_	_	_	_	
30-19	1692-1695	and	_	_	_	_	_	_	
30-20	1696-1702	weight	abstract[110]	new[110]	nonsal[110]	_	coref	30-22[111_110]	
30-21	1703-1705	is	_	_	_	_	_	_	
30-22	1706-1710	89.9	abstract[111]	giv[111]	nonsal[111]	_	coref	30-25[112_111]	
30-23	1711-1713	kg	abstract[111]	giv[111]	nonsal[111]	_	_	_	
30-24	1714-1715	(	_	_	_	_	_	_	
30-25	1716-1719	198	abstract[112]	new[112]	nonsal[112]	_	_	_	
30-26	1720-1726	pounds	abstract[112]	new[112]	nonsal[112]	_	_	_	
30-27	1727-1728	.	_	_	_	_	_	_	
30-28	1729-1730	)	_	_	_	_	_	_	

#Text=HEENT : Unremarkable except for some submandibular lymph nodes .
31-1	1731-1736	HEENT	abstract[113]	new[113]	nonsal[113]	_	_	_	
31-2	1737-1738	:	_	_	_	_	_	_	
31-3	1739-1751	Unremarkable	_	_	_	_	_	_	
31-4	1752-1758	except	_	_	_	_	_	_	
31-5	1759-1762	for	_	_	_	_	_	_	
31-6	1763-1767	some	object[114]	new[114]	nonsal[114]	_	_	_	
31-7	1768-1781	submandibular	object[114]	new[114]	nonsal[114]	_	_	_	
31-8	1782-1787	lymph	object[114]	new[114]	nonsal[114]	_	_	_	
31-9	1788-1793	nodes	object[114]	new[114]	nonsal[114]	_	_	_	
31-10	1794-1795	.	_	_	_	_	_	_	

#Text=His fundi are benign .
32-1	1796-1799	His	object[115]|person[116]	new[115]|giv[116]	nonsal[115]|nonsal[116]	_	coref	46-3[150_116]	
32-2	1800-1805	fundi	object[115]	new[115]	nonsal[115]	_	_	_	
32-3	1806-1809	are	_	_	_	_	_	_	
32-4	1810-1816	benign	_	_	_	_	_	_	
32-5	1817-1818	.	_	_	_	_	_	_	

#Text=NECK : Supple .
33-1	1819-1823	NECK	object[117]	new[117]	nonsal[117]	_	_	_	
33-2	1824-1825	:	_	_	_	_	_	_	
33-3	1826-1832	Supple	_	_	_	_	_	_	
33-4	1833-1834	.	_	_	_	_	_	_	

#Text=LUNGS : Clear to auscultation and percussion .
34-1	1835-1840	LUNGS	object[118]	new[118]	nonsal[118]	_	_	_	
34-2	1841-1842	:	_	_	_	_	_	_	
34-3	1843-1848	Clear	_	_	_	_	_	_	
34-4	1849-1851	to	_	_	_	_	_	_	
34-5	1852-1864	auscultation	abstract[119]	new[119]	nonsal[119]	_	_	_	
34-6	1865-1868	and	_	_	_	_	_	_	
34-7	1869-1879	percussion	abstract[120]	new[120]	nonsal[120]	_	_	_	
34-8	1880-1881	.	_	_	_	_	_	_	

#Text=CARDIAC : Reveals regular rate and rhythm without murmur , rub or gallop .
35-1	1882-1889	CARDIAC	_	_	_	_	_	_	
35-2	1890-1891	:	_	_	_	_	_	_	
35-3	1892-1899	Reveals	_	_	_	_	_	_	
35-4	1900-1907	regular	abstract[121]	new[121]	nonsal[121]	_	_	_	
35-5	1908-1912	rate	abstract[121]	new[121]	nonsal[121]	_	_	_	
35-6	1913-1916	and	abstract[121]	new[121]	nonsal[121]	_	_	_	
35-7	1917-1923	rhythm	abstract[121]|abstract[122]	new[121]|new[122]	nonsal[121]|nonsal[122]	_	_	_	
35-8	1924-1931	without	abstract[121]|abstract[122]	new[121]|new[122]	nonsal[121]|nonsal[122]	_	_	_	
35-9	1932-1938	murmur	abstract[121]|abstract[122]|event[123]	new[121]|new[122]|new[123]	nonsal[121]|nonsal[122]|nonsal[123]	_	_	_	
35-10	1939-1940	,	abstract[121]|abstract[122]	new[121]|new[122]	nonsal[121]|nonsal[122]	_	_	_	
35-11	1941-1944	rub	abstract[121]|abstract[122]|event[124]	new[121]|new[122]|new[124]	nonsal[121]|nonsal[122]|nonsal[124]	_	_	_	
35-12	1945-1947	or	abstract[121]|abstract[122]	new[121]|new[122]	nonsal[121]|nonsal[122]	_	_	_	
35-13	1948-1954	gallop	abstract[121]|abstract[122]|event[125]	new[121]|new[122]|new[125]	nonsal[121]|nonsal[122]|nonsal[125]	_	_	_	
35-14	1955-1956	.	_	_	_	_	_	_	

#Text=ABDOMEN : Soft and nontender without organomegaly or mass .
36-1	1957-1964	ABDOMEN	object[126]	new[126]	nonsal[126]	_	_	_	
36-2	1965-1966	:	_	_	_	_	_	_	
36-3	1967-1971	Soft	_	_	_	_	_	_	
36-4	1972-1975	and	_	_	_	_	_	_	
36-5	1976-1985	nontender	_	_	_	_	_	_	
36-6	1986-1993	without	_	_	_	_	_	_	
36-7	1994-2006	organomegaly	event[127]	new[127]	nonsal[127]	_	_	_	
36-8	2007-2009	or	_	_	_	_	_	_	
36-9	2010-2014	mass	object[128]	new[128]	nonsal[128]	_	_	_	
36-10	2015-2016	.	_	_	_	_	_	_	

#Text=EXTREMITIES : Show no cyanosis , clubbing or edema .
37-1	2017-2028	EXTREMITIES	object[129]	new[129]	nonsal[129]	_	_	_	
37-2	2029-2030	:	_	_	_	_	_	_	
37-3	2031-2035	Show	_	_	_	_	_	_	
37-4	2036-2038	no	_	_	_	_	_	_	
37-5	2039-2047	cyanosis	event[130]	new[130]	nonsal[130]	_	_	_	
37-6	2048-2049	,	_	_	_	_	_	_	
37-7	2050-2058	clubbing	event[131]	new[131]	nonsal[131]	_	_	_	
37-8	2059-2061	or	_	_	_	_	_	_	
37-9	2062-2067	edema	event[132]	new[132]	nonsal[132]	_	_	_	
37-10	2068-2069	.	_	_	_	_	_	_	

#Text=GU : Examination of the perineum revealed an open left gluteal wound that appears clear with no secretions .
38-1	2070-2072	GU	_	_	_	_	_	_	
38-2	2073-2074	:	_	_	_	_	_	_	
38-3	2075-2086	Examination	event[133]	new[133]	nonsal[133]	_	_	_	
38-4	2087-2089	of	event[133]	new[133]	nonsal[133]	_	_	_	
38-5	2090-2093	the	event[133]|object[134]	new[133]|new[134]	nonsal[133]|nonsal[134]	_	_	_	
38-6	2094-2102	perineum	event[133]|object[134]	new[133]|new[134]	nonsal[133]|nonsal[134]	_	_	_	
38-7	2103-2111	revealed	_	_	_	_	_	_	
38-8	2112-2114	an	object[135]	new[135]	nonsal[135]	_	coref	41-3[141_135]	
38-9	2115-2119	open	object[135]	new[135]	nonsal[135]	_	_	_	
38-10	2120-2124	left	object[135]	new[135]	nonsal[135]	_	_	_	
38-11	2125-2132	gluteal	object[135]	new[135]	nonsal[135]	_	_	_	
38-12	2133-2138	wound	object[135]	new[135]	nonsal[135]	_	_	_	
38-13	2139-2143	that	object[135]	new[135]	nonsal[135]	_	_	_	
38-14	2144-2151	appears	object[135]	new[135]	nonsal[135]	_	_	_	
38-15	2152-2157	clear	object[135]	new[135]	nonsal[135]	_	_	_	
38-16	2158-2162	with	object[135]	new[135]	nonsal[135]	_	_	_	
38-17	2163-2165	no	object[135]|object[136]	new[135]|new[136]	nonsal[135]|nonsal[136]	_	_	_	
38-18	2166-2176	secretions	object[135]|object[136]	new[135]|new[136]	nonsal[135]|nonsal[136]	_	_	_	
38-19	2177-2178	.	_	_	_	_	_	_	

#Text=IMPRESSION :
39-1	2179-2189	IMPRESSION	abstract[137]	new[137]	nonsal[137]	_	_	_	
39-2	2190-2191	:	_	_	_	_	_	_	

#Text=1. Human immunodeficiency virus disease with stable control on Atripla .
40-1	2192-2194	1.	_	_	_	_	_	_	
40-2	2195-2200	Human	abstract[138]|animal[139]	new[138]|giv[139]	nonsal[138]|nonsal[139]	_	_	_	
40-3	2201-2217	immunodeficiency	abstract[138]|animal[139]	new[138]|giv[139]	nonsal[138]|nonsal[139]	_	_	_	
40-4	2218-2223	virus	abstract[138]|animal[139]	new[138]|giv[139]	nonsal[138]|nonsal[139]	_	_	_	
40-5	2224-2231	disease	abstract[138]	new[138]	nonsal[138]	_	_	_	
40-6	2232-2236	with	abstract[138]	new[138]	nonsal[138]	_	_	_	
40-7	2237-2243	stable	abstract[138]	new[138]	nonsal[138]	_	_	_	
40-8	2244-2251	control	abstract[138]	new[138]	nonsal[138]	_	_	_	
40-9	2252-2254	on	abstract[138]	new[138]	nonsal[138]	_	_	_	
40-10	2255-2262	Atripla	abstract[138]|substance[140]	new[138]|giv[140]	nonsal[138]|nonsal[140]	Efavirenz/emtricitabine/tenofovir[140]	_	_	
40-11	2263-2264	.	_	_	_	_	_	_	

#Text=2. Resolving left gluteal abscess , completing Flagyl .
41-1	2265-2267	2.	_	_	_	_	_	_	
41-2	2268-2277	Resolving	_	_	_	_	_	_	
41-3	2278-2282	left	object[141]	new[141]	nonsal[141]	_	_	_	
41-4	2283-2290	gluteal	object[141]	new[141]	nonsal[141]	_	_	_	
41-5	2291-2298	abscess	object[141]	new[141]	nonsal[141]	_	_	_	
41-6	2299-2300	,	_	_	_	_	_	_	
41-7	2301-2311	completing	_	_	_	_	_	_	
41-8	2312-2318	Flagyl	substance[142]	giv[142]	nonsal[142]	Metronidazole[142]	_	_	
41-9	2319-2320	.	_	_	_	_	_	_	

#Text=3. Diabetes mellitus , currently on oral therapy .
42-1	2321-2323	3.	_	_	_	_	_	_	
42-2	2324-2332	Diabetes	abstract[143]	new[143]	nonsal[143]	Diabetes[143]	_	_	
42-3	2333-2341	mellitus	abstract[143]	new[143]	nonsal[143]	Diabetes[143]	_	_	
42-4	2342-2343	,	_	_	_	_	_	_	
42-5	2344-2353	currently	_	_	_	_	_	_	
42-6	2354-2356	on	_	_	_	_	_	_	
42-7	2357-2361	oral	abstract[144]	new[144]	nonsal[144]	_	_	_	
42-8	2362-2369	therapy	abstract[144]	new[144]	nonsal[144]	_	_	_	
42-9	2370-2371	.	_	_	_	_	_	_	

#Text=4. Hypertension .
43-1	2372-2374	4.	_	_	_	_	_	_	
43-2	2375-2387	Hypertension	abstract[145]	new[145]	nonsal[145]	_	_	_	
43-3	2388-2389	.	_	_	_	_	_	_	

#Text=5. Depression .
44-1	2390-2392	5.	_	_	_	_	_	_	
44-2	2393-2403	Depression	abstract[146]	new[146]	nonsal[146]	_	_	_	
44-3	2404-2405	.	_	_	_	_	_	_	

#Text=6. Chronic musculoskeletal pain of unclear etiology .
45-1	2406-2408	6.	_	_	_	_	_	_	
45-2	2409-2416	Chronic	abstract[147]	new[147]	nonsal[147]	_	_	_	
45-3	2417-2432	musculoskeletal	abstract[147]	new[147]	nonsal[147]	_	_	_	
45-4	2433-2437	pain	abstract[147]	new[147]	nonsal[147]	_	_	_	
45-5	2438-2440	of	abstract[147]	new[147]	nonsal[147]	_	_	_	
45-6	2441-2448	unclear	abstract[147]|abstract[148]	new[147]|new[148]	nonsal[147]|nonsal[148]	_	_	_	
45-7	2449-2457	etiology	abstract[147]|abstract[148]	new[147]|new[148]	nonsal[147]|nonsal[148]	_	_	_	
45-8	2458-2459	.	_	_	_	_	_	_	

#Text=PLAN : The patient will continue his current medications .
46-1	2460-2464	PLAN	abstract[149]	new[149]	sal[149]	_	_	_	
46-2	2465-2466	:	_	_	_	_	_	_	
46-3	2467-2470	The	person[150]	new[150]	nonsal[150]	_	coref	46-7[152_150]	
46-4	2471-2478	patient	person[150]	new[150]	nonsal[150]	_	_	_	
46-5	2479-2483	will	_	_	_	_	_	_	
46-6	2484-2492	continue	_	_	_	_	_	_	
46-7	2493-2496	his	abstract[151]|person[152]	new[151]|giv[152]	nonsal[151]|nonsal[152]	_	coref	47-1[153_152]	
46-8	2497-2504	current	abstract[151]	new[151]	nonsal[151]	_	_	_	
46-9	2505-2516	medications	abstract[151]	new[151]	nonsal[151]	_	_	_	
46-10	2517-2518	.	_	_	_	_	_	_	

#Text=He will have laboratory studies done in 3 to 4 weeks , and we will see him a few weeks thereafter .
47-1	2519-2521	He	person[153]	giv[153]	nonsal[153]	_	coref	47-17[157_153]	
47-2	2522-2526	will	_	_	_	_	_	_	
47-3	2527-2531	have	_	_	_	_	_	_	
47-4	2532-2542	laboratory	abstract[154]	new[154]	sal[154]	_	_	_	
47-5	2543-2550	studies	abstract[154]	new[154]	sal[154]	_	_	_	
47-6	2551-2555	done	_	_	_	_	_	_	
47-7	2556-2558	in	_	_	_	_	_	_	
47-8	2559-2560	3	time[155]	new[155]	sal[155]	_	coref	47-18[158_155]	
47-9	2561-2563	to	time[155]	new[155]	sal[155]	_	_	_	
47-10	2564-2565	4	time[155]	new[155]	sal[155]	_	_	_	
47-11	2566-2571	weeks	time[155]	new[155]	sal[155]	_	_	_	
47-12	2572-2573	,	_	_	_	_	_	_	
47-13	2574-2577	and	_	_	_	_	_	_	
47-14	2578-2580	we	person[156]	acc[156]	nonsal[156]	_	_	_	
47-15	2581-2585	will	_	_	_	_	_	_	
47-16	2586-2589	see	_	_	_	_	_	_	
47-17	2590-2593	him	person[157]	giv[157]	nonsal[157]	_	coref	48-1[159_157]	
47-18	2594-2595	a	time[158]	acc[158]	nonsal[158]	_	_	_	
47-19	2596-2599	few	time[158]	acc[158]	nonsal[158]	_	_	_	
47-20	2600-2605	weeks	time[158]	acc[158]	nonsal[158]	_	_	_	
47-21	2606-2616	thereafter	time[158]	acc[158]	nonsal[158]	_	_	_	
47-22	2617-2618	.	_	_	_	_	_	_	

#Text=He has been encouraged to keep his appointment with his psychologist .
48-1	2619-2621	He	person[159]	giv[159]	nonsal[159]	_	coref	48-7[161_159]	
48-2	2622-2625	has	_	_	_	_	_	_	
48-3	2626-2630	been	_	_	_	_	_	_	
48-4	2631-2641	encouraged	_	_	_	_	_	_	
48-5	2642-2644	to	_	_	_	_	_	_	
48-6	2645-2649	keep	_	_	_	_	_	_	
48-7	2650-2653	his	event[160]|person[161]	new[160]|giv[161]	nonsal[160]|nonsal[161]	_	coref	48-10[163_161]	
48-8	2654-2665	appointment	event[160]	new[160]	nonsal[160]	_	_	_	
48-9	2666-2670	with	event[160]	new[160]	nonsal[160]	_	_	_	
48-10	2671-2674	his	event[160]|person[162]|person[163]	new[160]|new[162]|giv[163]	nonsal[160]|nonsal[162]|nonsal[163]	_	_	_	
48-11	2675-2687	psychologist	event[160]|person[162]	new[160]|new[162]	nonsal[160]|nonsal[162]	_	_	_	
48-12	2688-2689	.	_	_	_	_	_	_	
